224 related articles for article (PubMed ID: 38275384)
1. Genetic Mutations Associated with Inflammatory Response Caused by HPV Integration in Oropharyngeal Squamous Cell Carcinoma.
Atique M; Muniz I; Farshadi F; Hier M; Mlynarek A; Macarella M; Maschietto M; Nicolau B; Alaoui-Jamali MA; da Silva SD
Biomedicines; 2023 Dec; 12(1):. PubMed ID: 38275384
[TBL] [Abstract][Full Text] [Related]
2. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
Fung N; Faraji F; Kang H; Fakhry C
Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
[TBL] [Abstract][Full Text] [Related]
3. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
4. Does smoking alter the mutation profile of human papillomavirus-driven head and neck cancers?
Mirghani H; Lacroix L; Rossoni C; Sun R; Aupérin A; Casiraghi O; Villepelet A; Lacave R; Faucher G; Marty V; Ferté C; Soria JC; Even C
Eur J Cancer; 2018 May; 94():61-69. PubMed ID: 29533868
[TBL] [Abstract][Full Text] [Related]
5. The molecular mechanism of human papillomavirus-induced carcinogenesis in head and neck squamous cell carcinoma.
Sano D; Oridate N
Int J Clin Oncol; 2016 Oct; 21(5):819-826. PubMed ID: 27339270
[TBL] [Abstract][Full Text] [Related]
6. Aetiological heterogeneity of head and neck squamous cell carcinomas: the role of human papillomavirus infections, smoking and alcohol.
Farsi NJ; Rousseau MC; Schlecht N; Castonguay G; Allison P; Nguyen-Tan PF; Souliéres D; Coutlée F; Hier M; Madathil S; Franco EL; Nicolau B
Carcinogenesis; 2017 Dec; 38(12):1188-1195. PubMed ID: 29029021
[TBL] [Abstract][Full Text] [Related]
7. The national landscape of human papillomavirus-associated oropharynx squamous cell carcinoma.
Liederbach E; Kyrillos A; Wang CH; Liu JC; Sturgis EM; Bhayani MK
Int J Cancer; 2017 Feb; 140(3):504-512. PubMed ID: 27667729
[TBL] [Abstract][Full Text] [Related]
8. Distress levels in patients with oropharyngeal vs. non-oropharyngeal squamous cell carcinomas of the head and neck over 1 year after diagnosis: a retrospective cohort study.
Schorr M; Carlson LE; Lau HY; Zhong L; Bultz BD; Waller A; Groff SL; Hao D
Support Care Cancer; 2017 Oct; 25(10):3225-3233. PubMed ID: 28600705
[TBL] [Abstract][Full Text] [Related]
9. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
Psyrri A; Rampias T; Vermorken JB
Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
[TBL] [Abstract][Full Text] [Related]
10. Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status.
Fullerton ZH; Butler SS; Mahal BA; Muralidhar V; Schoenfeld JD; Tishler RB; Margalit DN
Cancer; 2020 Apr; 126(7):1424-1433. PubMed ID: 31930488
[TBL] [Abstract][Full Text] [Related]
11. Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.
Faraji F; Eisele DW; Fakhry C
Laryngoscope Investig Otolaryngol; 2017 Feb; 2(1):10-18. PubMed ID: 28894817
[TBL] [Abstract][Full Text] [Related]
12. HPV Associated Head and Neck Cancer.
Spence T; Bruce J; Yip KW; Liu FF
Cancers (Basel); 2016 Aug; 8(8):. PubMed ID: 27527216
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status.
Huang SH; Waldron JN; Milosevic M; Shen X; Ringash J; Su J; Tong L; Perez-Ordonez B; Weinreb I; Bayley AJ; Kim J; Hope A; Cho BC; Giuliani M; Razak A; Goldstein D; Shi W; Liu FF; Xu W; O'Sullivan B
Cancer; 2015 Feb; 121(4):545-55. PubMed ID: 25336438
[TBL] [Abstract][Full Text] [Related]
14. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Optimal Assessment Schedules for Surveillance After Definitive Locoregional Treatment of Locally Advanced Head and Neck Cancer: A Retrospective Cohort Study With Parametric Modeling of Event-Free Survival.
Lee HI; Lee J; Lee JH; Wu HG; Kim JH; Kim Y; Eom KY
JAMA Otolaryngol Head Neck Surg; 2022 Nov; 148(11):1059-1067. PubMed ID: 36173618
[TBL] [Abstract][Full Text] [Related]
16. Human papilloma virus infection in head and neck cancer.
Tribius S; Hoffmann M
Dtsch Arztebl Int; 2013 Mar; 110(11):184-90, 190e1. PubMed ID: 23555322
[TBL] [Abstract][Full Text] [Related]
17. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
[TBL] [Abstract][Full Text] [Related]
19. Nodal staging convergence for HPV- and HPV+ oropharyngeal carcinoma.
Ho AS; Luu M; Kim S; Tighiouart M; Mita AC; Scher KS; Mallen-St Clair J; Walgama ES; Lin DC; Nguyen AT; Zumsteg ZS
Cancer; 2021 May; 127(10):1590-1597. PubMed ID: 33595897
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic Determinants of Susceptibility to Head and Neck Cancer in the Million Veteran Program Cohort.
Liu Y; Kramer JR; Sandulache VC; Yu R; Li G; Chen L; Yusuf ZI; Shi Y; Pyarajan S; Tsavachidis S; Jiao L; Mierzwa ML; Chiao E; Mowery YM; Shuman A; Shete S; Sikora AG; White DL
Cancer Res; 2023 Feb; 83(3):386-397. PubMed ID: 36378845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]